The average P/S ratio for HCM's competitors is 15.57, providing a benchmark for relative valuation. HUTCHMED (China) Ltd Corp (HCM) exhibits a P/S ratio of 4.04, which is -74.05% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.